Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Orchid Ventures Inc ORVRF

Orchid Ventures Inc is engaged in product development, branding, manufacturing, and distribution of vape products containing cannabis. It is a cannabis brand with THC and CBD product lines. Some of its vape products include Orchid Gold, Orchid Classics, Orchid Vibes, Orchid Roots and The Beast Orchid's Battery. It operates in a single geographical segment, which is North America.

GREY:ORVRF - Post Discussion

View:
Post by SuperMoney on Mar 03, 2021 2:55pm

ORCD

(1) Good to review the previous news released in FEB 3, 2021, “Orchid Ventures Enters into an Exclusive Licensing Agreement with Weedbox to Launch the Orchid Brand Throughout Canada”.

https://money.tmx.com/en/quote/ORCD:CNX/news/6034649996944871/Orchid_Ventures_Enters_into_an_Exclusive_Licensing_Agreement_with_Weedbox_to_Launch_the_Orchid_Brand_Throughout_Canada

This new indicated that “ According to the licensing agreement, to maintain exclusive rights to Orchid in Canada, Weedbox must be producing and selling 37,000 units per month by month 4 (four) of the agreement and 75,000 units per month by month 8 (eight). The company expects products to be ready for retail in early April 2021 pending Health Canada approval.”....

(2)
The latest MD&A (at page 8) indicated that “ Sales increased from the comparative period from $700,655 in YTD 2020 to $2,805,835 in YTD 2021 with the new initiatives discussed above. Gross profits increased from a gross loss of $239,787 in YTD 2020 to a gross profit of $1,610,608 in YTD 2021, reflecting the same trend.”.....

https://webfiles.thecse.com/ORCDQ2123120mda.pdf?tfp6N7MFdv_49O.y9Ar_dOIGsxVeT3nF

Comment by Dbrasco on Mar 03, 2021 3:10pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities